THERAPEUTIC CLASS

Efficacy and safety of COVID-19 vaccines in older people

---

Several vaccines against coronavirus disease 2019 (COVID-19) are on the cusp of regulatory approval.eir safety and efficacy
in older people is critical to their success. Even though care home residents and older people are likely to be amongst the first
to be vaccinated, these patient groups are usually excluded from clinical trials. Data from several Phase II trials have given
cause for optimism, with strong antibody responses and reassuring safety profiles but, with the exception of AstraZeneca’s
vaccine, recruited few older people.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

LITERATURE

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Allergy & Immune System

Specific Detail Info

Age and Ageing 2020; 1–5

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment